Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124647883 | 12464788 | 3 | F | 2016 | 20160726 | 20160614 | 20160729 | EXP | US-PFIZER INC-2016299358 | PFIZER | 80.00 | YR | F | Y | 59.90000 | KG | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124647883 | 12464788 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY (1 TABLET A DAY AFTER MEAL BY MOUTH) | 708BH | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 124647883 | 12464788 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, ALTERNATE DAY (EVERY OTHER DAY BY MOUTH) | 0 | 81 | MG | QOD | |||||||
| 124647883 | 12464788 | 3 | C | CALCIUM VITAMIN D3 | 2 | Oral | 1 DF, 1X/DAY (1000 MG-2500 MG 1 TABLET ONCE A DAY) | 0 | 1 | DF | TABLET | QD | |||||||
| 124647883 | 12464788 | 4 | C | CALCIUM VITAMIN D3 | 2 | 0 | TABLET | ||||||||||||
| 124647883 | 12464788 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK (2-3 TIMES PER DAY) | 0 | 500 | MG | TABLET | |||||||
| 124647883 | 12464788 | 6 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | QD | |||||||
| 124647883 | 12464788 | 7 | C | SOTALOL. | SOTALOL | 1 | Oral | 80 MG, 2X/DAY | 0 | 80 | MG | TABLET | BID | ||||||
| 124647883 | 12464788 | 8 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, DAILY (1 TABLET BY MOUTH DAILY) | 0 | 5 | MG | TABLET | |||||||
| 124647883 | 12464788 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, DAILY (1 TABLET BY MOUTH DAILY) | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124647883 | 12464788 | 1 | Breast cancer |
| 124647883 | 12464788 | 2 | Cardiac disorder |
| 124647883 | 12464788 | 3 | Bone disorder |
| 124647883 | 12464788 | 4 | Osteoporosis |
| 124647883 | 12464788 | 5 | Diabetes mellitus |
| 124647883 | 12464788 | 6 | Cardiac disorder |
| 124647883 | 12464788 | 7 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124647883 | 12464788 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124647883 | 12464788 | Condition aggravated | |
| 124647883 | 12464788 | Diverticulitis | |
| 124647883 | 12464788 | Drug dose omission | |
| 124647883 | 12464788 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124647883 | 12464788 | 1 | 201202 | 0 | ||
| 124647883 | 12464788 | 8 | 201606 | 0 | ||
| 124647883 | 12464788 | 9 | 201606 | 0 |